Regulation of α- synuclein expression by TRIM17 and TRIM41 Parkinson’s Diseasein

Solange Desagher

TRIM17 increases α-synuclein expression by inhibiting ubiquitination/degradation of the transcription factor ZSCAN21 mediated by TRIM41.

The aim is to assess:

  1. The role of this pathway in Parkinson’s disease models;
  2. The impact of TRIM41 and ZSCAN21 mutations identified in patients;
  3. The molecular mechanisms of TRIM41 inhibition by TRIM17.
More info